방사선종양학과 이태훈 교수

학력
2023.08	서울대학교 대학원 임상의과학과 박사 졸업
2021.02	서울대학교 대학원 의학과 방사선종양학전공 석사 졸업
2014.02	서울대학교 의과대학 의학과 학사 졸업
2010.02	서울대학교 자연과학대학 의예과 수료

경력
2024.03 ~현재	삼성서울병원 방사선종양학과 임상조교수
2023.03 ~ 2024.02	삼성서울병원 방사선종양학과 임상강사
2022.03 ~ 2023.02	서울대학교병원 방사선종양학과 임상강사
2018.05 ~ 2022.02	서울대학교병원 방사선종양학과 레지던트
2015.04 ~ 2018.04	육군 군의관 대위 전역
2014.03 ~ 2015.02	서울대학교병원 인턴

학회활동
2023.11 ~ 현재	대한방사선종양학회 재무간사
2022.03 ~ 현재	대한방사선종양학회 정회원

수상이력
2023.10	Travel Grant, Federation of Asian Organizations for Radiation Oncology &Korean Society for Radiation Oncology 2023 Meeting
2021.11	Best Presentation Award (Oral Presentation), 2021 Korean Association for Lung Cancer International Conference

J NEURO-ONCOL 2025 10.1007/s11060-025-04965-7 Distribution and failure patterns of primary central nervous system lymphoma related to the hippocampus: implications for hippocampal avoidance irradiation Ryu, H; Li, X; Lee, TH; Kim, TM; Choi, SH; Park, CK; Lee, ST; Park, SH; Won, JK; Jang, BS; Kim, IH; Lee, JH

View PubMed

SCI REP-UK 2024 10.1038/s41598-024-54976-z Androgen deprivation alone versus combined with pelvic radiation for adverse events and quality of life in clinically node-positive prostate cancer Lee, TH; Pyo, H; Yoo, GS; Kim, JH; Jeon, SS; Seo, SI; Jeong, BC; Jeon, HG; Sung, HH; Kang, M; Song, W; Chung, JH; Park, W

View PubMed

CANCER RES TREAT 2024 10.4143/crt.2023.1049 Assessment of Bone Marrow Involvement in Extranodal NK/T-Cell Lymphoma: Positron Emission Tomography versus Bone Marrow Biopsy, and the Significance of Minimal Involvement by EBV plus Cells (KROG 18-09) Lee, TH; Kim, HJ; Lee, JH; Lee, J; Kim, JH; Oh, D; Eom, KY

View PubMed

J MED IMAG RADIAT ON 2024 10.1111/1754-9485.13639 Hypofractionated radiation therapy combined with androgen deprivation therapy for high-risk localized prostate cancer Lee, TH; Pyo, H; Yoo, GS; Jeon, SS; Seo, SI; Jeong, BC; Jeon, HG; Sung, HH; Kang, MY; Song, W; Chung, JH; Bae, BK; Park, W

View PubMed

CANCERS 2024 10.3390/cancers16061235 Clinical Outcomes in Adenoid Cystic Carcinoma of the Nasal Cavity and Paranasal Sinus: A Comparative Analysis of Treatment Modalities Lee, TH; Kim, K; Oh, D; Yang, K; Jeong, HS; Chung, MK; Ahn, YC

View PubMed

CANCER MED-US 2024 10.1002/cam4.7023 A meta-analysis comparing efficacy and safety between proton beam therapy versus carbon ion radiotherapy Jang, JY; Kim, K; Chen, MF; Akimoto, T; Wang, MLC; Kim, MJ; Kim, K; Lee, TH; Yoo, GS; Park, HC

View PubMed

CANCER RES TREAT 2024 10.4143/crt.2023.996 Implication of Pre- and Post-radiotherapy ctDNA Dynamics in Patients with Residual Triple-Negative Breast Cancer at Surgery after Neoadjuvant Chemotherapy: Findings from a Prospective Observational Study Lee, TH; Kim, H; Kim, YJ; Park, WY; Park, W; Cho, WK; Kim, N

View PubMed

Cancer Med. 2023;12(14):15664-15675. doi: 10.1002/cam4.6169. 2023 Genomic landscape of locally advanced rectal adenocarcinoma: Comparison between before and after neoadjuvant chemoradiation and effects of genetic biomarkers on clinical outcomes and tumor response Lee TH¹, Jang BS, Chang JH, Kim E, Park JH, Chie EK

View PubMed

Prostate Int. 2023;11(3):173-179. doi: 10.1016/j.prnil.2023.07.002. 2023 Prostate-specific antigen kinetics in hypofractionated radiation therapy alone for intermediate- and high-risk localized prostate cancer Lee TH¹, Pyo H, Yoo GS, Lee HM, Jeon SS, Seo SI, Jeong BC, Jeon HG, Sung HH, Kang M, Song W, Chung JH, Bae BK, Park W

View PubMed

Cancer Res Treat. 2023;55(3):865-874. doi: 10.4143/crt.2022.1538. 2023 Predictors of post-chemoradiotherapy pulmonary complication in locally advanced non-small cell lung cancer Lee TH¹, Kang BH, Kim HJ, Wu HG, Lee JH

View PubMed

Cancer Res Treat. 2023;55(3):875-884. doi: 10.4143/crt.2022.1583. 2023 Efficacy of prophylactic cranial irradiation according to the risk of extracranial recurrence in limited-stage small cell lung cancer Lee TH¹, Chung JH, Wu HG, Kim S, Lee JH, Keam B, Kim JS, Kim KH, Kim BH, Kim HJ

View PubMed

Cancer Res Treat. 2023;55(1):258-269. doi: 10.4143/crt.2022.418. 2023 Image-guided versus conventional brachytherapy for locally advanced cervical cancer: experience of single institution with the same practitioner and time period Lee TH¹, Kim SK, Kim HJ, Choi CH, Kang S, Eom KY, Wee CW, Song YS, Park, NH, Kim JW, Chung HH, Kim HS, Lee M, Kang HC

View PubMed

Clin Oncol. 2023;35(6):e384-e394. doi: 10.1016/j.clon.2023.03.008. 2023 Stereotactic body radiation therapy for pulmonary metastasis from colorectal adenocarcinoma: biologically effective dose 150 Gy is preferred for tumour control Lee TH¹, Kang HC, Chie EK, Kim HJ, Wu HG, Lee JH, Kim KS

View PubMed

Radiat Oncol. 2023;18(1):68. doi: 10.1186/s13014-023-02255-y. 2023 Treatment outcomes of stereotactic body radiation therapy for pulmonary metastasis from sarcoma: a multicenter, retrospective study Lee TH¹, Kim HJ, Kim JH, Kim MS, Jang WI, Kim E, Kim KS

View PubMed

Radiother Oncol. 2023;183:109572. doi: 10.1016/j.radonc.2023.109572. 2023 Regional lymph node recurrence after stereotactic body radiation therapy for lung cancer: patterns of recurrence, treatment approaches, and clinical outcomes (KROG 21-09) Lee TH¹, Shin H, Ahn YC, Kang MK, Song C, Kim WC, Moon SH, Kim JH, Cho J, Park HJ, Lee HK, Kim BH, Kim HJ

View PubMed

J Oncol. 2022;2022:5635071. doi: 10.1155/2022/5635071. 2022 Comparable clinical outcome using small or large gross tumor volume-to-clinical target volume margin expansion in neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma Lee TH¹, Kim HJ, Kim BH, Kang CH, Keam B, Moon HJ, Seong YW, Kim S

View PubMed

Radiat Oncol J. 2022;40(2):120-126. doi: 10.3857/roj.2021.01025. 2022 Hypofractionated radiotherapy for early stage glottic cancer: efficacy of 3.5 Gy per fraction Lee TH¹, Lee JH, Kwon SK, Chung EJ, Wu HG

View PubMed

BMC Cancer. 2022;22(1):1179. doi: 10.1186/s12885-022-10285-0. 2022 Protocol for the postoperative radiotherapy in N1 breast cancer patients (PORT-N1) trial, a prospective multicenter, randomized, controlled, non-inferiority trial of patients receiving breast-conserving surgery or mastectomy Lee TH¹, Chang JH, Jang BS, Kim JS, Kim TH, Park W, Kim YB, Kim SS, Han W, Lee HB, Shin KH

View PubMed

Medicine (Baltimore). 2021;100(24):e26338. doi: 10.1097/md.0000000000026338. 2021 Comparison of endoscopically determined gross tumor volume and metabolic tumor volume in esophageal cancer Lee TH¹, Ryoo HG, Lee R, Paeng JC, Chung H, Kim HJ

View PubMed

Radiat Oncol. 2021;16(1):148. doi: 10.1186/s13014-021-01877-4. 2021 Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible Lee TH¹, Song C, Kim IA, Kim JS, Kim YB, Kim K, No JH, Suh DH, Chung JB, Eom KY

View PubMed

Radiat Oncol. 2021;16(1):222. doi: 10.1186/s13014-021-01948-6. 2021 Treatment outcomes of re-irradiation using stereotactic ablative radiotherapy to lung: a propensity score matching analysis Lee TH¹, Kim DY, Wu HG, Lee JH, Kim HJ

View PubMed

Radiat Oncol J. 2020;38(1):35-43. doi: 10.3857/roj.2020.00052. 2020 Reduced-dose whole-brain radiotherapy with tumor bed boost after upfront high-dose methotrexate for primary central nervous system lymphoma Lee TH¹, Lee JH, Chang JH, Ye SJ, Kim TM, Park CK, Kim IH, Kim BH, Wee CW

View PubMed

날짜					목 01	금 02	토 03	일 04	월 05	화 06	수 07	목 08	금 09	토 10	일 11	월 12	화 13	수 14	목 15	금 16	토 17	일 18	월 19	화 20	수 21	목 22	금 23	토 24	일 25	월 26	화 27	수 28	목 29	금 30	토 31
오전
오후

날짜	일 01	월 02	화 03	수 04	목 05	금 06	토 07	일 08	월 09	화 10	수 11	목 12	금 13	토 14	일 15	월 16	화 17	수 18	목 19	금 20	토 21	일 22	월 23	화 24	수 25	목 26	금 27	토 28	일 29	월 30
오전
오후

게재일	2014-10-22
발표년월	2012-05	구분	국내
학술지	가정의학회지
논문명(국문)
논문명(영문)
요약문	td	발행정보	2010;31(10):778-785
책임저자	이정권
저자	박주현, 이선진, 곽정임, 심재용, 이정권	제 1저자	박주현
초록첨부	test
논문첨부

방사선종양학과 이태훈 교수

학력

경력

학회활동

수상이력